Status
Acquired by The Medicines Company on August 5, 2013
Funding Received
$22 Million in 2 Rounds from 2 Investors
Headquarters:
Leiden
Description:
ProFibrix is a biotech company developing and commercializing products for the hemostasis and regenerative medicine markets.
Categories:
Biotechnology
Website:
http://www.profibrix.com

Company Details

Update

ProFibrix B.V., a biotech company, creates, develops, and markets products for the hemostasis and regenerative medicine markets. Its products include Fibrocaps, a dry powder topical hemostat and tissue sealant based on a mixture of fibrinogen and thrombin, which stops acute and severe bleeding during surgery or in connection with trauma injury. The company also provides a sterilized single-use delivery device to deliver Fibrocaps to the target tissue area without the need to manipulate the wound in a surgical environment. It offers its products based on human fibrinogen, a natural blood protein for haemostasis, blood clotting, and tissue repair and healing. ProFibrix B.V. was founded in 2004

Funding Rounds (2) - $22M

Update

Investors (2)

Update

Offices/Locations (1)

Update
  • HQ

    Zernikedreef 9

    Leiden, 2333

    NLD

Images (1)

Update
  • A3cef1b75b3cb7c1807c99b42a5b9dae